enzyme is a true cathepsin L. No enzyme with properties of cathepsin B were detected in T. cnrzi, although the enzyme described by Cazzulo and co-workers [3-51 has some features in common with cathepsin B.
We are investigating the peptidases of Trypanosoma cmzi, the protozoan parasite that causes South American trypanosomiasis. All stages of the life cycle of this parasite express a peptidase that cleaves on the carboxyl side of arginine and lysine residues of p-nitroanilide (pNA) and amidomethylcoumarin (MCA) substrates at alkaline pH [I] . In the absence of added reducing agents the alkaline peptidase is the major enzyme in detergent extracts of T. cruzi epimastigotes that cleaves these substrates at pH 8.0. We have detected, on the basis of pH profile, substrate specificity and inhibitor sensitivity as well as electrophoretic mobility, a similar enzyme in 15 other species of trypanosomatid, including African trypanosomes and Leishmania [I]. Because we have not detected a similar enzyme in any nontrypanosomatid protozoa or mammalian cells that we have tested, we hypothesize that the alkaline peptidase is specific to organisms of the phylogenetic order, Kinetoplastida, or to the family, Trypanosomatida.
We have examined the alkaline peptidase of T. cruzi epimastigotes for its ability to cleave peptidyl-MCA substrates and for its sensitivity to a range of irreversible and reversible inhibitors. Purified T. cruzi alkaline peptidase was found to cleave Bz-Arg-MCA with a K , of about 12 p~. However, when a second basic residue is added to the arginine residue, as in Cbz-Arg-Arg-MCA, the K, falls by an order of magnitude to about 1 p~. All substrates examined that contained two basic residues (Cbz-Arg-Arg-MCA, Cbz-Gly-Arg-Arg-MCA, Cbz-Leu-Gly-Arg-MCA, CbzAsn-Arg-Arg-MCA, Cbz-Gly-Lys-Arg-MCA and Cbz-LeuLys-Arg-MCA) had a K , value of about 1 p~, whereas all other substrates had a K, greater than 10 p~. The Vma. values for the substrates containing two basic residues are also lower than those for other substrates. From the data, it is apparent that the alkaline peptidase prefers arginine or lysine The alkaline peptidase is sensitive to Tos-Lys-CH,CI, leupeptin, diisopropylfluorophosphate (DFP) and to peptidyldiazomethanes containing arginine or lysine at P 1. Since DFP generally inhibits serine peptidases, whereas diazo- 634th MEETING, BATH methanes are considered to be cysteine peptidase inhibitors 131, the class of peptidase to which the enzyme belongs is unclear and must await sequence data on the enzyme protein. Unlike most cysteine peptidases, the enzyme is not inhibited by E64 or iodoacetic acid. Certain organic bases, and especially those resembling arginine or lysine side-chains, also inhibit the T. cnizi alkaline peptidase. Thus, n-butylamine and agmatine inhibit the enzyme. Indeed, hirudonin and the anti-protozoal drug, pentamidine, are effective reversible inhibitors of the peptidase and, in agreement with the substrate preference for pairs of basic residues, these compounds resemble two arginine residues joined together. Figure I shows the T. cruzi alkaline peptidase as detected in polyacrylamide gels using the fluorogenic substrate, BzArg-MCA. A single band of fluoresence occurs in total detergent extracts of T. cnrzi, in agreement with our hypothesis that the parasite has one major enzyme that cleaves this substrate [ l ] . The intensity of this band is reduced by leupeptin, Tos-Lys-CHzCI and Cbz-Leu-Lys-diazomethane, which agrees exactly with the inhibitor profile of the purified enzyme as determined using solution assays.
The occurrence of the trypanosomatid alkaline peptidase as a major enzyme in T. cruzi and other trypanosomatids suggests that it is fundamental to these organisms. Its study should contribute to our knowledge of peptidases and to our understanding of organisms that cause some of the most devastating maladies of man.
The kinetoplastid protozoan Leishmuniu donovuni is the causative agent of visceral leishmaniasis (VL), a disease widespread in tropical and subtropical regions of the world.
A llgt I I cDNA library was prepared from L. dono~ani mRNA and screened with sera from VL-infected patients. Inserts from positive cDNA clones were used to isolate the corresponding genomic DNA clones from a L-EMBL3 library, which were then analysed to determine the sequence [I] . This protocol led to the identification of a member of the 70 kDa heat-shock protein family (Hsp7O) as a major immunogen of the parasite. A series of recombinant deletion constructs was prepared, in the expression vector Bluescript (Stratagene). These were screened by Western blotting using sera from VL patients to determine regions containing B cell epitopes. An immunodominant epitope was identified in the ('-terminal region of the protein which was recognized by 90% o f sera tested.
To map this epitope further, the region Lys-495-Ser-634, was synthesized as a set of overlapping peptides (10 mer overlapped by 5 ) on the Pepscan system (Cambridge Research Biochemicals) [ 21. The peptides are synthesized o n to polyetheylene pins which have been coated with polyacrylic acid and derivatized with hexamethylene diamine. Deprotection of the pins by piperidine/dimethylformamide (DMF), followed by washing with DMF and methanol, precedes the attachment of the first Fmoc amino acids 131. The cycle is repeated until the desired peptide is synthesized. Peptides encompassing the C-terminal region of Hsp7O were reacted with serum from a patient ( T F ) with VL. Two peaks of activity were identified Met-525-Glu-534 and Ser-615-Pro-624. A second set of peptides were synthesized covering the 525-534 region ( 10 mer overlapping by 9) and again tested with TF serum. The results (Fig. 1 ) clearly demonstrate that the epitope is EADDRA (528-533), as adjacent peptides which lose any of the above amino acids do not give a positive signal.
This epitope is found in a poorly conserved region of the protein and may have an application in the diagnosis of VL.
The second epitope identified by the peptide screening is currently being evaluated against a panel of sera from VLinfected patients to determine what role it may play in the humoral response to L. donovuni infection.
At this stage, ihe side-chain protecting groups are removed I . MacFarlane, J., Blaxter, M. L., Bishop, R. P., Miles, M. A. & and the peptides can be screened with antibodies in a simple
